Discover how much money can be saved in your clinical trial!

Screen Shot 2019 04 23 at 4.01.09 PM

Research Sites Cooperate To Prevent Duplicate Subjects in CNS Clinical Trials By Using The Verified Clinical Trials Research Subject Registry

Duplicate subjects exist in most clinical trials to varying degrees.  CNS clinical trials are especially  prone to duplicate subject or over enrollment.  The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications.  Use of global research subject database registry such as Verified Clinical Trials will help …

Read more

Screen Shot 2019 04 23 at 4.01.09 PM

Professional Research Subjects Travel: Prevent Duplicate Subjects In Your Clinical Trials With Verified Clinical Trials

Mature data collected from North America as well as in Europe demonstrates how research volunteers will travel large distances to screen or enroll contemporaneously in multiple clinical trials as duplicate subjects in clinical trials. The numbers are significant and occur across both early and later phase studies. Why risk these safety and data quality issues? …

Read more

Screenshot 2017 06 03 09.56.26 1

Duplicate Subjects In Clinical Trials Can Be Prevented With A Global Research Subject Registry

Duplicate subjects in clinical trials is unfortunately a common issue that affects all trials from most every indication and across all phases of clinical trials research.  These professional research subjects can be prevented by using Verified Clinical Trials (VCT) the global research subject registry.  Nearly all of the phase 1 units across the United States …

Read more

Screen Shot 2019 03 31 at 10.25.15 PM

Duplicate Subjects In Your Clinical Trials Result In Safety & Data Quality Issues

To maintain data integrity and safety, it is necessary to highlight and detect duplicate subjects in your clinical trials proactively.  This is true for nearly all therapeutic indications and all phases of clinical trials research.  Duplicate enrollment (over enrollment) is NOT just a healthy volunteer phase 1 issue.  The global research subject database registry VCT data over the …

Read more

Screen Shot 2019 03 31 at 10.34.14 PM

Having a system, or research subject database registry, to proactively detect and prevent duplicate subjects and other protocol violations has become a well recognized and important step to protect the data quality and improve research subject safety. This is NOT limited to phase 1 healthy volunteer studies. This happens with significant frequency across multiple therapeutic …

Read more

Screen Shot 2019 03 29 at 9.23.10 AM

Bad Behavior in Clinical Trials: Strategies to Combat Duplicate Subjects & Research Participant Dishonesty/Deception, Non-adherence, and “Professional Subjects

Join us at #ASCP2019 in Phoenix this year Wed. May 29th at 1 PM as VCT hosts an expert panel on professional research subjects and duplicate subjects in CNS clinical trials.  Duplicate subjects can ruin a trial, especially in the CNS space.  Without a research subject database registry like Verified Clinical Trials it is nearly impossible …

Read more

Duplicate subjects or professional research subjects are many times the silent killer in your clinical trials

Duplicate subjects in clinical trials result in increased placebo rates and poor quality data. This is oftentimes the silent killer of your study. www.verifiedclinicaltrials.com (VCT) is the global research subject database registry that is utilized by countless sites and sponsors worldwide.  Duplicate subjects in clinical trials cause safety and dat quality issues.  They drive up the …

Read more

Screen Shot 2019 03 16 at 3.15.28 PM

Using Verified Clinical Trials’ Database Registry to Determine the Prevalence of and Prevent Inclusion/Exclusion Related Protocol Violations in Early Phase Clinical Trials

Yulan Zhang from Verified Clinical Trials presenting a poster at #ASCPT2019 “Using Verified Clinical Trials’ Database Registry to Determine the Prevalence of and Prevent Inclusion/Exclusion Related Protocol Violations in Early Phase Clinical Trials”. VCT prevents duplicate subjects in clinical trials. The data demonstrates how VCT prospectively determines the prevalence of and prevent inclusion/exclusion related protocol …

Read more

Screen Shot 2019 03 16 at 3.01.41 PM

Duplicate Subjects In Clinical Trials Cause Safety & Data Quality Issues

Duplicate subjects in clinical trials result in safety and data quality issues.  The global Verified Clinical Trials research subject database registry system is used around the world to prevent duplicate subjects in clinical trials.  Typical higher risk clinical trials can see double digit incidence rates of protocol violations that will be prevented by Verified Clinical …

Read more

Screen Shot 2019 02 07 at 1.32.54 PM

Professional Research Subjects: Not Just a Regional Problem

Preventable protocol violations and professional research subjects exist across the globe. It is NOT just a regional problem. If you look at the protocol violations by verification with the Verified Clinical Trials (VCT) system one can see that the issue is significant throughout the country. Duplicate subjects can cause a trial to fail.  Issues with increased …

Read more